Related Experiment Video
Updated: Jul 20, 2026

08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Peptidomics for cancer diagnosis: present and future
1Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada. ediamandis@mtsinai.on.ca
Journal of Proteome Research
|September 2, 2006
Abstract:
Analysis of peptides in biological fluids by mass spectrometry holds promise of providing diagnostic and prognostic information for cancer and other diseases. Before this technology is used clinically, it is important to understand its advantages and limitations. These are summarized, along with proposals, on how to proceed in the future.

